Table 1.
Antibacterial and antimycobacterial activities of IBC.
| Species | MIC (µg/mL) | ||||
|---|---|---|---|---|---|
| IBC | Tetracycline | Chlorhexidine | Isoniazid | ||
| Gram-positive | MSSA | 1.56 | 0.20 | - | - |
| MRSA | 3.12 | >5.90 | - | - | |
| Streptococcus pneumoniae | 50.0 | 0.40 | - | - | |
| Streptococcus sanguinis | 3.12 | - | 1.82 | - | |
| Streptococcus sobrinus | 6.25 | - | 3.64 | - | |
| Streptococcus mutans | 6.25 | - | 0.91 | - | |
| Mycobacterium avium | 62.5 | - | - | 0.50 | |
| Mycobacteria | Mycobacterium kansasii | 62.5 | - | - | 1.00 |
| Mycobacterium tuberculosis | 62.5 | - | - | >1.00 | |
| Gram-negative | Pseudomonas aeruginosa | >400 | 5.90 | - | - |
| Klebsiella pneumoniae | >400 | 2.95 | - | - | |
MSSA = Methicillin-susceptible Staphylococcus aureus; MRSA = Methicillin-resistant Staphylococcus aureus.